Latest Positron Corp (POSC) Headlines New Par
Post# of 5
Posted On: 03/11/2014 1:13:50 AM
Latest Positron Corp (POSC) Headlines
New Partnership Agreement with the National Association of Attorneys General
M2 - Tue Feb 25, 6:25AM CST
Ambassador William R. Brownfield, Assistant Secretary of State for the Bureau of International Narcotics and Law Enforcement Affairs (INL), signed a partnership agreement today with Attorney General J.B. Van Hollen of Wisconsin, President of the National Association of Attorneys General (NAAG). Under this partnership, NAAG's National Attorneys General Training and Research Institute and INL will cooperate on advancing the development of rule-of-law institutions with partner countries around the world.
Concise Analysis of the International Radiopharmaceuticals Market
M2 - Fri Feb 14, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/5ltj8g/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - France (2) - Germany (2) - The United Kingdom (4) - Italy (2) - Spain (1) - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5l...rmaceutica
Omeros Reports Additional Positive Phase 1 Clinical Data for OMS824 for the Treatment of Cognitive Disorders
PR Newswire - Tue Feb 11, 6:00AM CST
Omeros Corporation (NASDAQ: OMER) today announced additional positive data from its Phase 1 program for OMS824, the lead compound in Omeros' phosphodiesterase 10 (PDE10) program. This clinical trial evaluated the extent to which OMS824 binds to PDE10, an enzyme expressed in the region of the brain that has been linked to a wide range of diseases that affect cognition. In the latest cohort enrolled in this trial, OMS824 achieved a high of approximately 70--percent engagement at PDE10 without evidence of extrapyramidal symptoms (EPS). These data further support the potential of OMS824 to have a high therapeutic index in the treatment of patients with schizophrenia, Huntington's disease and other cognitive disorders. Omeros is completing a Phase 2a trial evaluating the drug in patients with schizophrenia and will start enrollment in a Phase 2 trial for Huntington's disease this quarter.
Cytogenetics Report - Technologies, Markets and Companies - 2014
M2 - Mon Feb 10, 10:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/m53hk3/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering. This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. Historical landmarks in the evolution of cytogenetics are reviewed since the first images of chromosomes were made in 1879. The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH. Molecular cytogenetics includes application of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection. Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies. FISH remains the single most important technology in cytogenetics. Several innovations are described of which the most important are single copy FISH, in vivo FISH (imaging of nucleic acids in living cells) and nanotechnology-based FISH. The unique character of peptide nucleic acid (PNA) allows these probes to hybridize to target nucleic acid molecules more rapidly and with higher affinity and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies for cytogenetics promise to speed up detection of chromosome aberrations now examined by FISH. Other important genomic technologies are whole genome expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic applications. Optical Mapping can survey entire human genomes for insertions/deletions, which account for a significantly greater proportion of genetic variation between closely-related genomes as compared to single nucleotide polymorphisms (SNPs), and are a major cause of gene defects. Technologies encompassed within molecular imaging include optical imaging, magnetic resonance imaging (MRI) and nuclear medicine techniques. Positron emission tomography (PET) is the most sensitive and specific technique for imaging molecular pathways in vivo in humans. Cytogenetics can be refined by application of cytogenetics at single molecule level. Nanotechnology has facilitated the development of technology for single molecule imaging. Atomic force microscope (AFM) has become a well-established technique for imaging single biomolecules under physiological conditions. The scanning probe microscope (SPM) system is emerging as an increasingly important tool for non-intrusive interrogation of biomolecular systems in vitro and have been applied to improve FISH. Another example of application of nanobiotechnology is QD (quantum dot)-FISH probes, which can detect down to the single molecule level. There are connections between cytogenetics and biomarkers of genetic disorders as well as cancer. Biomarkers are very important for molecular diagnostics. Not only are molecular diagnostic technologies used for discovery of biomarkers, biomarkers are the basis of several diagnostics. As a means to understand pathomechanism of disease and as links between diagnostics and therapeutics, biomarkers are playing a role in development of personalized medicine. Application of cytogenetics extend beyond genetic disorder and cancer to diagnosis of several other diseases. Other important applications are drug discovery, and development of personalized medicine. The chapter on markets provides a global perspective of the cytogenetics business in the major markets: US, Western Europe (including France, Germany, Italy, Spain, and the UK), and Japan. The total figures for the market are also broken out according to the technologies and major disease areas in which they are applied. Markets figure are given for the year 2013 and estimates are made for the years 2018 and 2023. Advantages and limitations of various technologies have been pointed out throughout the report but this chapter includes SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis of some of the competing technologies including the following: conventional FISH, innovative FISH technologies, PCR-based assays, and single molecule imaging. Unfulfilled needs in cytogenetics market are depicted graphically. Among various technologies, FISH is most advanced and less opportunities for further development than single molecule detection, which is in infancy and has more future potential. Key Topics Covered: Executive Summary 1. Introduction 2. Technologies used for cytogenetics 3. Fluorescent In Situ Hybridization 4. Genomic Technologies relevant to Cytogenetics 5. Molecular Imaging & Single Molecular Detection 6. Role of Nanobiotechnology in Cytogenetics 7. Biomarkers and Cytogenetics 8. Applications of Cytogenetics 9. Cancer Cytogenetics 10. Cytogenetics Markets 11. Companies 12. References For more information visit http://www.researchandmarkets.com/research/m5...togenetics Source: Jain PharmaBiotech
2013 Report on the International Radiopharmaceuticals Market - Trends And Forecasts to 2018
M2 - Thu Jan 23, 3:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/fhpj27/radiopharmaceutica) has announced the addition of the "2013 Report on the International Radiopharmaceuticals Market - Trends And Forecasts to 2018" report to their offering. There is tremendous growth potential the radiopharmaceuticals market, especially in developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal antibodies has opened new boulevards for the growth of the global radiopharmaceuticals market. Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many useful properties of gamma-emitting tracer nuclide. This report analyses the global scenario of the radiopharmaceuticals market, discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data, and forecasts the radiopharmaceuticals market size, production forecasts along with key factors driving and restraining the market. The report also analyzes the radiopharmaceuticals market by generators and by further classifying them in terms of medical isotopes, their applications, end users and geographic distribution. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Global Radiopharmaceuticals Market Overview 4 Market Definition & Supply Chain Analysis 4.1 Market Definition 4.2 Radiopharmaceutical Production : A Global Perspective 4.3 Supply Chain Analysis 5 Global Radiopharmaceutical Generators Market 5.1 Overview 5.2 Mo-99/Tc-99m Generators 5.3 Sr-82/Rb-82 Generators 5.4 Ge-68/Ga-67,68 Generators 5.5 Sr-90/Y-90 Generators 5.6 W-188/Re-188 Generators 6 Global Radiopharmaceuticals Market, By End-User Groups 6.1 Overview 6.2 Hospitals and Medical Centers 6.3 Outpatient Diagnostic Centers 7 Global Radiopharmaceuticals Market, By Applications 8 Global Radiopharmaceuticals Market, By Geography 8.1 Overview 8.2 North America 8.3 Europe 8.4 Asia-Pacific (Apac) 8.5 Rest of the World 9 Market Share Analysis By Key Players 9.1 Radiopharmaceuticals Market 9.2 Generators Market 10 Recommendations 10.1 Identification and Elimination Of Barriers 10.2 Development of Total Solutions 10.3 Investing in Emerging Markets 10.4 Entering Monopoly Markets 11 Company Profiles Companies Mentioned: - Cardinal Health - Covidien - GE Healthcare - IBA Group - Lantheus Medical Imaging - Monrol Nuclear Products - NTP Radioisotopes - Nordion - Polatom - Positron Corporation - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/fh...rmaceutica
Global Medical Imaging Equipment Market Report 2013-2019: In-Depth X-ray, Ultrasound, CT, MRI and Nuclear Imaging Analysis
M2 - Wed Jan 15, 9:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/wn7p65/medical_imaging) has announced the addition of the "Global Medical Imaging Equipment Market Report 2013-2019" report to their offering. The report studies the global medical imaging equipment market based on the various types of equipments (product categories) as well as the different technologies used in each product segment. The five major categories of imaging equipments studied in this report include X-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging equipments. The market has also been segmented into four major geographies of the world, namely, North America, Europe, Asia-Pacific and Rest of the World. The market sizes and forecasts for each segment of the market have been calculated for the period 2011-2019 considering 2012 as the base year and have been expressed in the report in terms of USD million. The CAGR % for the forecast period 2013 to 2019 has also been provided for each market segment and sub-segment. A detailed qualitative analysis of the market dynamics, based on factors like drivers, restraints and opportunities has been presented in the market overview section of the report. This section also includes the Porter's five force analysis and market attractiveness analysis by geography for the global medical imaging equipment market. Market share analysis by key players operating in this market has been included in terms of percent share in the year 2012, in the competitive landscape section of the report. Scope of the Report Product Types X-ray Devices - Stationary X-ray Devices - Portable X-ray Devices Computed Tomography (CT) Scanners - Stationary CT - Portable/Mobile CT Ultrasound Systems - Trolley/Cart based ultrasound - Compact/Portable ultrasound Magnetic Resonance Imaging (MRI) Equipment - Closed MRI - Open MRI Nuclear Imaging Equipment - Single Photon Emission Computed Tomography (SPECT) Scanners - Positron Emission Tomography (PET) Scanners Technology X-ray Devices - Analog - Computed radiography (CR) - Digital radiography (DR) Computed Tomography (CT) Scanners - Low-slice scanners - Medium-slice scanners - High-slice scanners Ultrasound Systems - 2-D Imaging - 3-D & 4-D Imaging - Doppler - HIFU - Lithotripsy Magnetic Resonance Imaging (MRI) Equipment - High-field - Medium-field - Low-field Nuclear Imaging Equipment - Single Photon Emission Computed Tomography (SPECT) - Positron Emission Tomography (PET) Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Medical Imaging Equipment Market, by Product Type, 2011 - 2019 (USD Million) Chapter 5 Global Medical Imaging Equipment Market, by Technology, 2011 - 2019 (USD Million) Chapter 6 Global Medical Imaging Equipment Market, by Geography, 2011 - 2019 (USD Million) Chapter 7 Competitive Landscape Chapter 8 Recommendations Chapter 9 Company Profiles - Carestream Health, Inc - Fonar Corporation - Fujifilm Holdings Corporation - GE Healthcare Ltd - Genesis Medical Imaging, Inc - Hitachi Medical Corporation - Hologic, Inc - Philips Healthcare - Samsung Medison Co Ltd - Shimadzu Corporation - Siemens Healthcare - Toshiba America Medical Systems Inc For more information visit http://www.researchandmarkets.com/research/wn...al_imaging
Global Mobile and Wireless Backhaul Market Report 2013 - 2018
M2 - Mon Jan 13, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/89vfkq/mobile_and) has announced the addition of the "Global Mobile and Wireless Backhaul Market Report 2013 - 2018" report to their offering. Mobile and wireless backhaul refers to a section of mobile and wireless networks, which facilitates the transportation of mobile data traffic. With continuous increase in deployment of 4G/LTE, popularity of small cells, and availability and usage of smart devices, the mobile operators are facing challenges with traditional legacy backhaul networks. Up-gradation of wireless technology alone is not sufficient for delivering quality services to customers, so mobile operators have to go for evolved backhaul networks. In the present scenario, mobile and wireless backhaul networks are evolving from hauling voice-only traffic to voice and video traffic. This transition requires high-bandwidth capacity to accommodate such large data traffic along with maintaining the delivery of quality mobile services to the end customer. Mobile operators in the wireless industry are bound to boost their backhauling techniques and make huge investments in their networks to support profitability with performance. Also, in order to improve revenue growth, the operators need to uphold the networks compatible with 2G, 3G, High-Speed Packet Access (HSPA), Long-Term Evolution (LTE) technologies. The market is booming, and in the near future it will present momentous potential opportunity to various mobile operators, backhaul equipment vendors, and service providers. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Market Size And Forecast By Equipment 5 Market Size And Forecast By Services 6 Market Size And Forecast By Regions 7 Market Landscape 8 Company Profiles Companies Mentioned: - Airspan Networks - Alcatel-Lucent - Alpha Omega Wireless - BTI Systems - Blinq Networks - Bluwan - Bridgewave Comunications - Broadcom Corporation - Brocade - Cambridge Broadband Network Ltd - Cisco - Dragonwave - Ericsson - Fastback Networks - Fsona - Fujitsu - Huawei - Hughes - Intracom - Jdsu - Max4G - NEC - Nokia Siemens Networks - Orange Telecom - Positron Access - Radwin - Siklu - Sub10 Systems - Transmode - Vitesse Semiconductor - Vubiq - ZTE For more information visit http://www.researchandmarkets.com/research/89vfkq/mobile_and
Breast Imaging Technologies Market (Digital Mammography, Molecular Breast Imaging) worth $5 Billion - 2017
M2 - Mon Dec 16, 4:30AM CST
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" , is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
GE Healthcare Delivers Innovative Technology to Advance Cancer Care
Business Wire - Wed Dec 04, 9:00AM CST
As part of its ongoing commitment to accelerating cancer innovation and assembling tools to fight the disease, GE Healthcare, a unit of General Electric Company (NYSE: GE), will highlight the benefits of the company's broad portfolio of advanced cancer treatment solutions at the 2013 Radiological Society of North America (#RSNA13) annual meeting. GE's innovations, including Positron Emission Tomography (PET), Molecular Breast Imaging (MBI) and Automated Whole Breast Ultrasound System (ABUS) diagnostic imaging procedures, provide clinicians with improved tools to better detect cancer and monitor therapy. These breakthrough offerings are in the spirit of GE Healthcare's $1 billion commitment to fight cancer.
2013 Report on the International Medical Imaging Market
M2 - Fri Nov 29, 6:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/c8285j/medical_imaging) has announced the addition of the "2013 Report on the International Medical Imaging Market" report to their offering. Picture archiving and communication systems (PACS) and contrast agents are the sub-segments in medical imaging market that have gained significant growth in recent years. As a result of these medical imaging advancements, the multi-slice systems are generating large volumes of data, and this creates demand for data storage, 3-D visualization and analysis. This research report also profiles the main companies involved in the international medical imaging market. In this section, each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Key Topics Covered: 1. Overview 1.1 Statement of This Report 1.2 Scope of This Report 1.3 Methodology 1.4 Executive Summary 2. Medical Imaging Technologies: An Overview 2.1 X-Ray 2.2 Computed Radiography 2.3 Digital Radiography 2.4 Fluoroscopy and C-Arms Systems 2.5 Mammography 2.6 Bone Densitometry Scanners 2.7 Computed Tomography 2.8 MRI Scanners 2.9 Ultrasound Scanners 2.10 Nuclear Imaging 2.11 Nuclear Medicine 3. Medical Indications for the Currently Available Imaging Modalities 3.1 Medical Imaging in Cancer Care 3.2 Global Incidence of Cardiovascular Diseases 3.3 Global Incidence of Neurological Disorders 3.4 Musculoskeletal Disorders 4. Medical Imaging: Market Analysis 5. Relative Use of Imaging Modalities in Future 6. Company Profiles Companies Mentioned - 3mensio Medical Imaging - Agfa Healthcare NV - B-K Medical ApS - Biosound Esaote, Inc. - Canon U.S.A., Inc. - GE Healthcare - Hologic, Inc. - Philips Healthcare - Positron Corporation - Siemens Healthcare - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/c8...al_imaging
Global Radiopharmaceutical Market 2012-2016: Increasing Demand for Radiopharmaceuticals is Expected to Fuel the Growth in this Market
M2 - Fri Nov 29, 6:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/ltk889/global) has announced the addition of the "Global Radiopharmaceutical Market 2012-2016" report to their offering. The analysts forecast the Global Radio Pharmaceutical market to grow at a CAGR of 18.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Radio Pharmaceutical market has also been witnessing the increasing demand for radiopharmaceuticals. However, the short half-life could pose a challenge to the growth of this market. The key vendors dominating this market space are Cardinal Health Inc., Covidien plc, Lantheus Medical Imaging Inc., and IBA Molecular Inc. Other vendors mentioned in the report are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Algeta ASA, Bio-Nucleonics Inc., GE Healthcare Ltd., Monrol Nuclear Products Inc., Molecular Insight Pharmaceuticals Inc., Nordion Inc., Novelos Therapeutics Inc., NTP Radioisotopes (Pty) Ltd., Positron Corp., and Siemens Healthcare. Commenting on the report, an analyst from the team said: As a result of the rise in the incidences of cardiovascular, oncological, and neurological disorders among the population, there has been an increase in procedural volumes for PET, SPECT, SPECT-CT, PET-MRI, and SPECT-MRI procedures for imaging and diagnosis. Imaging without utilization of radiopharmaceuticals has become indispensable owing to their ability to enable diagnosis of various disease processes much earlier than other diagnostic test procedures. For instance, the increasing number of oncology and cardiology procedures is expected to drive the demand for radiopharmaceuticals such as fluorodeoxyglucose used for PET scans. Thus, increasing demand for radiopharmaceuticals is expected to fuel the growth in this market. According to the report, one of the main drivers in this market is the increasing aging population globally and the associated increase in incidences of cardiovascular diseases, neurological disorders, gastrointestinal diseases and oncological disorders among the aged population. The rise in demand for diagnostic screening of elderly patients has enhanced the need for radiopharmaceuticals. For more information visit http://www.researchandmarkets.com/research/ltk889/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Analysis of the European Refurbished Medical Imaging Equipment Market
M2 - Tue Nov 26, 3:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/8xwgzb/analysis_of_the) has announced the addition of the "Analysis of the European Refurbished Medical Imaging Equipment Market" report to their offering. Trends and Dynamics in the Used or Pre-owned Medical Imaging Systems Market This research service provides an in-depth analysis of the European refurbished medical imaging equipment market. It analyses the revenue potential, market dynamics, and trends across countries in Central and Eastern Europe and Western Europe as a combined European market. The revenue of the European refurbished medical imaging equipment market has been derived from studying the dynamics of different segments. The refurbished medical imaging equipment market has been segmented based on geographies as well. Key Questions Answered - Is the demand for imaging systems in smaller hospitals and private clinics growing, how will it influence the refurbished medical imaging equipment market? Is the European market expected to grow? How long will it continue to grow and at what rate? - What is the scope of growth in the refurbished medical imaging equipment market, and what opportunities are important to leverage in view of the future? - As hospitals are cutting down their expenditure, would refurbished systems cater efficiently to their imaging needs? Do these systems help in catering to the highly indebted hospitals in regions impacted by the Eurozone crisis? - How does the political and reimbursement scenario in some regions of Europe affect the market? - What important trends are expected to have an impact on the market in the future? Executive Summary - CEO's perspective 1 . Global acceptance of refurbished systems has led to its wide-scale acceptance in the European healthcare market. 2. The availability of high-end products at low prices encourages emerging private hospitals to opt for refurbished imaging equipment. 3. Effective servicing and product warranty would help win customer loyalty and break the taboo against refurbished systems. 4. A shift from linear distribution to circular distribution would compensate for market weakness in one region by gaining strength in another. 5. Financial constraints in the mostly untapped CEE region promises high growth prospects for low priced refurbished imaging systems. Key Topics Covered - Executive Summary - Market Overview - General X-ray Segment Breakdown - Ultrasound Segment Breakdown - Magnetic Resonance Segment Breakdown - Computed Tomography Segment Breakdown - X-ray Mammography Segment Breakdown - Interventional X-ray Segment Breakdown - Positron Emission Tomography Segment Breakdown - Germany Breakdown - France Breakdown - The United Kingdom Breakdown - Italy Breakdown - Spain Breakdown - Benelux Breakdown - Scandinavia Breakdown - Poland Breakdown - Hungary Breakdown - The Czech Republic Breakdown - Bulgaria Breakdown - Romania Breakdown - The Last Word For more information visit http://www.researchandmarkets.com/research/8x...sis_of_the About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Positron Corporation elects Joseph Oliverio as president
M2 - Fri Nov 15, 6:44AM CST
Nuclear medicine company Positron Corporation (OTC Markets
OSC) stated on Thursday that it has hired Joseph G. Oliverio as its president.
Positron Appoints Joseph Oliverio As President
PR Newswire - Thu Nov 14, 4:09PM CST
Positron Corporation (OTCBB OSC) (the "Company"), a nuclear medicine healthcare company, is pleased to announce the appointment of Joseph G. Oliverio as its President. Mr. Oliverio will direct the Company's cardiac PET mission and oversee Positron's PET technology, radiopharmaceutical partnerships, clinical and technical applications for new customer sales and exiting users.
Global Positron Emission Tomography Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
PR Newswire - Thu Nov 07, 3:30AM CST
New Market Research Report Added in MarketResearchReports.Biz Reports Database: Global Positron Emission Tomography Market 2012-2016
Global Radiopharmaceuticals Market Report 2013 - 2018
M2 - Wed Nov 06, 5:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/q28q7t/radiopharmaceutica) has announced the addition of the "Global Radiopharmaceuticals Market Report 2013 - 2018" report to their offering. Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage, bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of iron metabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow of cerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroid diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin B12 from intestines, red blood cell diseases, salivary gland diseases, spleen diseases, stomach and intestinal bleeding, stomach problems, tear duct blockage, thyroid diseases, thyroid cancer and urinary bladder diseases. This may be given to the patient in a number of ways, for e.g. they may be given through the mouth, through injections or placed into the eye or into the bladder. It is a small treatment, which includes use of simple substances containing radioactive isotopes. While treating cancer, these radioactive agents are taken up in the cancerous area to destroy the affected tissues. It works effectively by targeting the areas in the body where the cancer is present. Individuals are suggested to intake radiopharmaceuticals only under the direct supervision of a doctor. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Global Radiopharmaceuticals Market Overview 4 Market Definition & Supply Chain Analysis 5 Global Radiopharmaceutical Generators Market 5.1 Overview 5.2 Mo-99/Tc-99m Generators 5.3 Sr-82/Rb-82 Generators 5.4 Ge-68/Ga-67,68 Generators 5.5 Sr-90/Y-90 Generators 5.6 W-188/Re-188 Generators 6 Global Radiopharmaceuticals Market, By End-User Groups 7 Global Radiopharmaceuticals Market, By Applications 7.1 Overview 7.2 Radiopharmaceuticals For Diagnosis 7.3 Radiopharmaceuticals For Therapy 7.4 Theranostics 8 Global Radiopharmaceuticals Market, By Geography 8.1 Overview 8.2 North America 8.3 Europe 8.4 Asia-Pacific (Apac) 8.5 Rest of the World (RoW) 9 Market Share Analysis By Key Players 9.1 Radiopharmaceuticals Market 9.2 Generators Market 10 Recommendations 11 Company Profiles Companies Mentioned - Cardinal Health Inc. - Covidien Plc - GE Healthcare - IBA Group - Lantheus Medical Imaging - Monrol Nuclear Products, Inc. - Nordion, Inc. - NTP Radioisotopes (Pty) Ltd - Polatom - Positron Corporation - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/q2...rmaceutica
Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI) Worth $5 Billion - 2017 - New Report by MarketsandMarkets
PRWeb - Sat Nov 02, 11:01AM CDT
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017", is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
Global Healthcare/Medical Simulation Market Repor 2013-2017: By Product, Technology, End-Users & Services Analysis
M2 - Fri Nov 01, 9:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4c3qmq/healthcaremedical) has announced the addition of the "Global Healthcare/Medical Simulation Market Repor 2013-2017" report to their offering. 'Healthcare/Medical Simulation Market - By Product (Patient Simulator, Surgical Simulator, Imaging Simulation, Task Trainer), Technology (Haptic, Virtual Reality), End-Users (Academics, Hospitals, Military) & Services- Trends & Global Forecasts To 2017' This research report largely categorizes the global market for healthcare/medical simulation into products and services. This market is broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. The market is also evaluated by end-users and comprehensively analyzed at a granular level by region (North America, Europe, Asia, and Rest of the World). Global Healthcare/medical simulation Products & Services Market: - High Fidelity Mannequin/ Patient Simulators - Simulated Clinical Environments - Live environments - Virtual environments - Second life - Serious games - Interventional simulation - Surgical simulators - Cardiovascular simulators - IV simulators - Endovascular simulators - Ultrasound simulators - Mid / Low Fidelity Task Trainers - Imaging Simulation - Ultrasound Imaging - Magnetic Resonance Imaging (MRI) - Computed Tomography (CT) - Positron Emission Tomography (PET) - Performance Recording - Healthcare/medical simulation training services Technology Landscape: - Haptics - Virtual reality Global Healthcare / Medical Simulation Market, by End-Users: - Academics - Hospitals - Military - Other Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Medical Simulation Products & Services Market 5 Technology Landscape 6 Applications Market 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - B Scientific Gmbh - Anesoft Corporation - Anomalous Medical - Biodigital Systems, Llc - B-Line Medical, Llc (Subsidiary Ofatellis, Inc. ) - CAE, Ltd. - Education Management Solutions, Inc. (EMS) - Gaumard Scientific Company, Inc. - Immersion Corporation - Ingmar Medical, Ltd. - Kyoto Kagaku Co., Ltd. - Laerdal Medical AS - Limbs & Things Ltd - Medical Simulation Corporation - Mentice AB - Promodel Corporation - Simbionix Usa Corporation - Simulab Corporation - Surgical Science Sweden AB For more information visit http://www.researchandmarkets.com/research/4c...aremedical
Global Positron Emission Tomography Market 2012-2016
M2 - Wed Oct 30, 4:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3qdnd8/global_positron) has announced the addition of the "Global Positron Emission Tomography Market 2012-2016" report to their offering. Global Positron Emission Tomography Market Expected To Grow At A CAGR Of 3.74 Percent Over The Period 2012-2016 The report, the Global PET Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. Commenting on the report, an analyst from the researchers' team said: The combination of PET with other imaging equipment such as MRI, CT, and X-ray will provide high-resolution images of the physiological and anatomical behavior of the body. This will in turn help to understand the disease in an effective way. Currently, only the top three companies in the market have introduced hybrid systems such as PET/MRI technology, namely, GE Healthcare, Siemens Healthcare and Philips Healthcare. Siemens Healthcare's Biograph mMR is the most advanced hybrid comprising of a PET/CT that scans the patients once and takes only 30 minutes for imaging and generating the image. This equipment is currently used for clinical research at Massachusetts General Hospital. Currently, PET/MRI scanning is limited to the experimental stage; however, with the development of new tracer molecules and the optimization of PET/MRI procedures, it could boost the use of PET/MRI scanning methods in clinical settings. GE Healthcare is also in the process of developing trimodality scanning equipment consisting of PET/CT/MRI scanning. The trend toward the development of fusion modalities is expected to revolutionize the Global PET market. According to the report, one of the major drivers in this market is the increase in the aging population. The increase in the aging population has led to a high incidence of diseases such as cancer, Alzheimer's, and cardiovascular disorders. This is expected to boost the procurement of PET scanners in all the geographical regions. Further, the report states that one of the major challenges in this market is the economic recession and its impact, especially in the EMEA region. This is expected to reduce the adoption rate of PET scanners and thereby reduce the potential revenues for the market. The major factor for this is the fluctuations in regional currencies. The poor economy is also expected to further reduce the reimbursement options and support from the individual governments. Key Topics Covered 1. Executive Summary 2. Scope of the Report 3. Market Research Methodology 4. List of Abbreviations 5. Introduction 6. Market Landscape 7. Market Segmentation by Application 8. Market Segmentation by Technology 9. Geographical Segmentation 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Key Vendor Analysis Companies Mentioned - Capintec - GE Healthcare - Hitachi Medical systems USA - Mediso Medical Imaging Systems - Naviscan - Philips Healthcare - Positron Corp. - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/3q...l_positron About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
New Partnership Agreement with the National Association of Attorneys General
M2 - Tue Feb 25, 6:25AM CST
Ambassador William R. Brownfield, Assistant Secretary of State for the Bureau of International Narcotics and Law Enforcement Affairs (INL), signed a partnership agreement today with Attorney General J.B. Van Hollen of Wisconsin, President of the National Association of Attorneys General (NAAG). Under this partnership, NAAG's National Attorneys General Training and Research Institute and INL will cooperate on advancing the development of rule-of-law institutions with partner countries around the world.
Concise Analysis of the International Radiopharmaceuticals Market
M2 - Fri Feb 14, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/5ltj8g/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - France (2) - Germany (2) - The United Kingdom (4) - Italy (2) - Spain (1) - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5l...rmaceutica
Omeros Reports Additional Positive Phase 1 Clinical Data for OMS824 for the Treatment of Cognitive Disorders
PR Newswire - Tue Feb 11, 6:00AM CST
Omeros Corporation (NASDAQ: OMER) today announced additional positive data from its Phase 1 program for OMS824, the lead compound in Omeros' phosphodiesterase 10 (PDE10) program. This clinical trial evaluated the extent to which OMS824 binds to PDE10, an enzyme expressed in the region of the brain that has been linked to a wide range of diseases that affect cognition. In the latest cohort enrolled in this trial, OMS824 achieved a high of approximately 70--percent engagement at PDE10 without evidence of extrapyramidal symptoms (EPS). These data further support the potential of OMS824 to have a high therapeutic index in the treatment of patients with schizophrenia, Huntington's disease and other cognitive disorders. Omeros is completing a Phase 2a trial evaluating the drug in patients with schizophrenia and will start enrollment in a Phase 2 trial for Huntington's disease this quarter.
Cytogenetics Report - Technologies, Markets and Companies - 2014
M2 - Mon Feb 10, 10:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/m53hk3/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering. This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. Historical landmarks in the evolution of cytogenetics are reviewed since the first images of chromosomes were made in 1879. The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH. Molecular cytogenetics includes application of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection. Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies. FISH remains the single most important technology in cytogenetics. Several innovations are described of which the most important are single copy FISH, in vivo FISH (imaging of nucleic acids in living cells) and nanotechnology-based FISH. The unique character of peptide nucleic acid (PNA) allows these probes to hybridize to target nucleic acid molecules more rapidly and with higher affinity and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies for cytogenetics promise to speed up detection of chromosome aberrations now examined by FISH. Other important genomic technologies are whole genome expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic applications. Optical Mapping can survey entire human genomes for insertions/deletions, which account for a significantly greater proportion of genetic variation between closely-related genomes as compared to single nucleotide polymorphisms (SNPs), and are a major cause of gene defects. Technologies encompassed within molecular imaging include optical imaging, magnetic resonance imaging (MRI) and nuclear medicine techniques. Positron emission tomography (PET) is the most sensitive and specific technique for imaging molecular pathways in vivo in humans. Cytogenetics can be refined by application of cytogenetics at single molecule level. Nanotechnology has facilitated the development of technology for single molecule imaging. Atomic force microscope (AFM) has become a well-established technique for imaging single biomolecules under physiological conditions. The scanning probe microscope (SPM) system is emerging as an increasingly important tool for non-intrusive interrogation of biomolecular systems in vitro and have been applied to improve FISH. Another example of application of nanobiotechnology is QD (quantum dot)-FISH probes, which can detect down to the single molecule level. There are connections between cytogenetics and biomarkers of genetic disorders as well as cancer. Biomarkers are very important for molecular diagnostics. Not only are molecular diagnostic technologies used for discovery of biomarkers, biomarkers are the basis of several diagnostics. As a means to understand pathomechanism of disease and as links between diagnostics and therapeutics, biomarkers are playing a role in development of personalized medicine. Application of cytogenetics extend beyond genetic disorder and cancer to diagnosis of several other diseases. Other important applications are drug discovery, and development of personalized medicine. The chapter on markets provides a global perspective of the cytogenetics business in the major markets: US, Western Europe (including France, Germany, Italy, Spain, and the UK), and Japan. The total figures for the market are also broken out according to the technologies and major disease areas in which they are applied. Markets figure are given for the year 2013 and estimates are made for the years 2018 and 2023. Advantages and limitations of various technologies have been pointed out throughout the report but this chapter includes SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis of some of the competing technologies including the following: conventional FISH, innovative FISH technologies, PCR-based assays, and single molecule imaging. Unfulfilled needs in cytogenetics market are depicted graphically. Among various technologies, FISH is most advanced and less opportunities for further development than single molecule detection, which is in infancy and has more future potential. Key Topics Covered: Executive Summary 1. Introduction 2. Technologies used for cytogenetics 3. Fluorescent In Situ Hybridization 4. Genomic Technologies relevant to Cytogenetics 5. Molecular Imaging & Single Molecular Detection 6. Role of Nanobiotechnology in Cytogenetics 7. Biomarkers and Cytogenetics 8. Applications of Cytogenetics 9. Cancer Cytogenetics 10. Cytogenetics Markets 11. Companies 12. References For more information visit http://www.researchandmarkets.com/research/m5...togenetics Source: Jain PharmaBiotech
2013 Report on the International Radiopharmaceuticals Market - Trends And Forecasts to 2018
M2 - Thu Jan 23, 3:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/fhpj27/radiopharmaceutica) has announced the addition of the "2013 Report on the International Radiopharmaceuticals Market - Trends And Forecasts to 2018" report to their offering. There is tremendous growth potential the radiopharmaceuticals market, especially in developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal antibodies has opened new boulevards for the growth of the global radiopharmaceuticals market. Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many useful properties of gamma-emitting tracer nuclide. This report analyses the global scenario of the radiopharmaceuticals market, discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data, and forecasts the radiopharmaceuticals market size, production forecasts along with key factors driving and restraining the market. The report also analyzes the radiopharmaceuticals market by generators and by further classifying them in terms of medical isotopes, their applications, end users and geographic distribution. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Global Radiopharmaceuticals Market Overview 4 Market Definition & Supply Chain Analysis 4.1 Market Definition 4.2 Radiopharmaceutical Production : A Global Perspective 4.3 Supply Chain Analysis 5 Global Radiopharmaceutical Generators Market 5.1 Overview 5.2 Mo-99/Tc-99m Generators 5.3 Sr-82/Rb-82 Generators 5.4 Ge-68/Ga-67,68 Generators 5.5 Sr-90/Y-90 Generators 5.6 W-188/Re-188 Generators 6 Global Radiopharmaceuticals Market, By End-User Groups 6.1 Overview 6.2 Hospitals and Medical Centers 6.3 Outpatient Diagnostic Centers 7 Global Radiopharmaceuticals Market, By Applications 8 Global Radiopharmaceuticals Market, By Geography 8.1 Overview 8.2 North America 8.3 Europe 8.4 Asia-Pacific (Apac) 8.5 Rest of the World 9 Market Share Analysis By Key Players 9.1 Radiopharmaceuticals Market 9.2 Generators Market 10 Recommendations 10.1 Identification and Elimination Of Barriers 10.2 Development of Total Solutions 10.3 Investing in Emerging Markets 10.4 Entering Monopoly Markets 11 Company Profiles Companies Mentioned: - Cardinal Health - Covidien - GE Healthcare - IBA Group - Lantheus Medical Imaging - Monrol Nuclear Products - NTP Radioisotopes - Nordion - Polatom - Positron Corporation - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/fh...rmaceutica
Global Medical Imaging Equipment Market Report 2013-2019: In-Depth X-ray, Ultrasound, CT, MRI and Nuclear Imaging Analysis
M2 - Wed Jan 15, 9:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/wn7p65/medical_imaging) has announced the addition of the "Global Medical Imaging Equipment Market Report 2013-2019" report to their offering. The report studies the global medical imaging equipment market based on the various types of equipments (product categories) as well as the different technologies used in each product segment. The five major categories of imaging equipments studied in this report include X-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging equipments. The market has also been segmented into four major geographies of the world, namely, North America, Europe, Asia-Pacific and Rest of the World. The market sizes and forecasts for each segment of the market have been calculated for the period 2011-2019 considering 2012 as the base year and have been expressed in the report in terms of USD million. The CAGR % for the forecast period 2013 to 2019 has also been provided for each market segment and sub-segment. A detailed qualitative analysis of the market dynamics, based on factors like drivers, restraints and opportunities has been presented in the market overview section of the report. This section also includes the Porter's five force analysis and market attractiveness analysis by geography for the global medical imaging equipment market. Market share analysis by key players operating in this market has been included in terms of percent share in the year 2012, in the competitive landscape section of the report. Scope of the Report Product Types X-ray Devices - Stationary X-ray Devices - Portable X-ray Devices Computed Tomography (CT) Scanners - Stationary CT - Portable/Mobile CT Ultrasound Systems - Trolley/Cart based ultrasound - Compact/Portable ultrasound Magnetic Resonance Imaging (MRI) Equipment - Closed MRI - Open MRI Nuclear Imaging Equipment - Single Photon Emission Computed Tomography (SPECT) Scanners - Positron Emission Tomography (PET) Scanners Technology X-ray Devices - Analog - Computed radiography (CR) - Digital radiography (DR) Computed Tomography (CT) Scanners - Low-slice scanners - Medium-slice scanners - High-slice scanners Ultrasound Systems - 2-D Imaging - 3-D & 4-D Imaging - Doppler - HIFU - Lithotripsy Magnetic Resonance Imaging (MRI) Equipment - High-field - Medium-field - Low-field Nuclear Imaging Equipment - Single Photon Emission Computed Tomography (SPECT) - Positron Emission Tomography (PET) Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Medical Imaging Equipment Market, by Product Type, 2011 - 2019 (USD Million) Chapter 5 Global Medical Imaging Equipment Market, by Technology, 2011 - 2019 (USD Million) Chapter 6 Global Medical Imaging Equipment Market, by Geography, 2011 - 2019 (USD Million) Chapter 7 Competitive Landscape Chapter 8 Recommendations Chapter 9 Company Profiles - Carestream Health, Inc - Fonar Corporation - Fujifilm Holdings Corporation - GE Healthcare Ltd - Genesis Medical Imaging, Inc - Hitachi Medical Corporation - Hologic, Inc - Philips Healthcare - Samsung Medison Co Ltd - Shimadzu Corporation - Siemens Healthcare - Toshiba America Medical Systems Inc For more information visit http://www.researchandmarkets.com/research/wn...al_imaging
Global Mobile and Wireless Backhaul Market Report 2013 - 2018
M2 - Mon Jan 13, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/89vfkq/mobile_and) has announced the addition of the "Global Mobile and Wireless Backhaul Market Report 2013 - 2018" report to their offering. Mobile and wireless backhaul refers to a section of mobile and wireless networks, which facilitates the transportation of mobile data traffic. With continuous increase in deployment of 4G/LTE, popularity of small cells, and availability and usage of smart devices, the mobile operators are facing challenges with traditional legacy backhaul networks. Up-gradation of wireless technology alone is not sufficient for delivering quality services to customers, so mobile operators have to go for evolved backhaul networks. In the present scenario, mobile and wireless backhaul networks are evolving from hauling voice-only traffic to voice and video traffic. This transition requires high-bandwidth capacity to accommodate such large data traffic along with maintaining the delivery of quality mobile services to the end customer. Mobile operators in the wireless industry are bound to boost their backhauling techniques and make huge investments in their networks to support profitability with performance. Also, in order to improve revenue growth, the operators need to uphold the networks compatible with 2G, 3G, High-Speed Packet Access (HSPA), Long-Term Evolution (LTE) technologies. The market is booming, and in the near future it will present momentous potential opportunity to various mobile operators, backhaul equipment vendors, and service providers. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Market Size And Forecast By Equipment 5 Market Size And Forecast By Services 6 Market Size And Forecast By Regions 7 Market Landscape 8 Company Profiles Companies Mentioned: - Airspan Networks - Alcatel-Lucent - Alpha Omega Wireless - BTI Systems - Blinq Networks - Bluwan - Bridgewave Comunications - Broadcom Corporation - Brocade - Cambridge Broadband Network Ltd - Cisco - Dragonwave - Ericsson - Fastback Networks - Fsona - Fujitsu - Huawei - Hughes - Intracom - Jdsu - Max4G - NEC - Nokia Siemens Networks - Orange Telecom - Positron Access - Radwin - Siklu - Sub10 Systems - Transmode - Vitesse Semiconductor - Vubiq - ZTE For more information visit http://www.researchandmarkets.com/research/89vfkq/mobile_and
Breast Imaging Technologies Market (Digital Mammography, Molecular Breast Imaging) worth $5 Billion - 2017
M2 - Mon Dec 16, 4:30AM CST
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" , is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
GE Healthcare Delivers Innovative Technology to Advance Cancer Care
Business Wire - Wed Dec 04, 9:00AM CST
As part of its ongoing commitment to accelerating cancer innovation and assembling tools to fight the disease, GE Healthcare, a unit of General Electric Company (NYSE: GE), will highlight the benefits of the company's broad portfolio of advanced cancer treatment solutions at the 2013 Radiological Society of North America (#RSNA13) annual meeting. GE's innovations, including Positron Emission Tomography (PET), Molecular Breast Imaging (MBI) and Automated Whole Breast Ultrasound System (ABUS) diagnostic imaging procedures, provide clinicians with improved tools to better detect cancer and monitor therapy. These breakthrough offerings are in the spirit of GE Healthcare's $1 billion commitment to fight cancer.
2013 Report on the International Medical Imaging Market
M2 - Fri Nov 29, 6:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/c8285j/medical_imaging) has announced the addition of the "2013 Report on the International Medical Imaging Market" report to their offering. Picture archiving and communication systems (PACS) and contrast agents are the sub-segments in medical imaging market that have gained significant growth in recent years. As a result of these medical imaging advancements, the multi-slice systems are generating large volumes of data, and this creates demand for data storage, 3-D visualization and analysis. This research report also profiles the main companies involved in the international medical imaging market. In this section, each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Key Topics Covered: 1. Overview 1.1 Statement of This Report 1.2 Scope of This Report 1.3 Methodology 1.4 Executive Summary 2. Medical Imaging Technologies: An Overview 2.1 X-Ray 2.2 Computed Radiography 2.3 Digital Radiography 2.4 Fluoroscopy and C-Arms Systems 2.5 Mammography 2.6 Bone Densitometry Scanners 2.7 Computed Tomography 2.8 MRI Scanners 2.9 Ultrasound Scanners 2.10 Nuclear Imaging 2.11 Nuclear Medicine 3. Medical Indications for the Currently Available Imaging Modalities 3.1 Medical Imaging in Cancer Care 3.2 Global Incidence of Cardiovascular Diseases 3.3 Global Incidence of Neurological Disorders 3.4 Musculoskeletal Disorders 4. Medical Imaging: Market Analysis 5. Relative Use of Imaging Modalities in Future 6. Company Profiles Companies Mentioned - 3mensio Medical Imaging - Agfa Healthcare NV - B-K Medical ApS - Biosound Esaote, Inc. - Canon U.S.A., Inc. - GE Healthcare - Hologic, Inc. - Philips Healthcare - Positron Corporation - Siemens Healthcare - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/c8...al_imaging
Global Radiopharmaceutical Market 2012-2016: Increasing Demand for Radiopharmaceuticals is Expected to Fuel the Growth in this Market
M2 - Fri Nov 29, 6:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/ltk889/global) has announced the addition of the "Global Radiopharmaceutical Market 2012-2016" report to their offering. The analysts forecast the Global Radio Pharmaceutical market to grow at a CAGR of 18.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Radio Pharmaceutical market has also been witnessing the increasing demand for radiopharmaceuticals. However, the short half-life could pose a challenge to the growth of this market. The key vendors dominating this market space are Cardinal Health Inc., Covidien plc, Lantheus Medical Imaging Inc., and IBA Molecular Inc. Other vendors mentioned in the report are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Algeta ASA, Bio-Nucleonics Inc., GE Healthcare Ltd., Monrol Nuclear Products Inc., Molecular Insight Pharmaceuticals Inc., Nordion Inc., Novelos Therapeutics Inc., NTP Radioisotopes (Pty) Ltd., Positron Corp., and Siemens Healthcare. Commenting on the report, an analyst from the team said: As a result of the rise in the incidences of cardiovascular, oncological, and neurological disorders among the population, there has been an increase in procedural volumes for PET, SPECT, SPECT-CT, PET-MRI, and SPECT-MRI procedures for imaging and diagnosis. Imaging without utilization of radiopharmaceuticals has become indispensable owing to their ability to enable diagnosis of various disease processes much earlier than other diagnostic test procedures. For instance, the increasing number of oncology and cardiology procedures is expected to drive the demand for radiopharmaceuticals such as fluorodeoxyglucose used for PET scans. Thus, increasing demand for radiopharmaceuticals is expected to fuel the growth in this market. According to the report, one of the main drivers in this market is the increasing aging population globally and the associated increase in incidences of cardiovascular diseases, neurological disorders, gastrointestinal diseases and oncological disorders among the aged population. The rise in demand for diagnostic screening of elderly patients has enhanced the need for radiopharmaceuticals. For more information visit http://www.researchandmarkets.com/research/ltk889/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Analysis of the European Refurbished Medical Imaging Equipment Market
M2 - Tue Nov 26, 3:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/8xwgzb/analysis_of_the) has announced the addition of the "Analysis of the European Refurbished Medical Imaging Equipment Market" report to their offering. Trends and Dynamics in the Used or Pre-owned Medical Imaging Systems Market This research service provides an in-depth analysis of the European refurbished medical imaging equipment market. It analyses the revenue potential, market dynamics, and trends across countries in Central and Eastern Europe and Western Europe as a combined European market. The revenue of the European refurbished medical imaging equipment market has been derived from studying the dynamics of different segments. The refurbished medical imaging equipment market has been segmented based on geographies as well. Key Questions Answered - Is the demand for imaging systems in smaller hospitals and private clinics growing, how will it influence the refurbished medical imaging equipment market? Is the European market expected to grow? How long will it continue to grow and at what rate? - What is the scope of growth in the refurbished medical imaging equipment market, and what opportunities are important to leverage in view of the future? - As hospitals are cutting down their expenditure, would refurbished systems cater efficiently to their imaging needs? Do these systems help in catering to the highly indebted hospitals in regions impacted by the Eurozone crisis? - How does the political and reimbursement scenario in some regions of Europe affect the market? - What important trends are expected to have an impact on the market in the future? Executive Summary - CEO's perspective 1 . Global acceptance of refurbished systems has led to its wide-scale acceptance in the European healthcare market. 2. The availability of high-end products at low prices encourages emerging private hospitals to opt for refurbished imaging equipment. 3. Effective servicing and product warranty would help win customer loyalty and break the taboo against refurbished systems. 4. A shift from linear distribution to circular distribution would compensate for market weakness in one region by gaining strength in another. 5. Financial constraints in the mostly untapped CEE region promises high growth prospects for low priced refurbished imaging systems. Key Topics Covered - Executive Summary - Market Overview - General X-ray Segment Breakdown - Ultrasound Segment Breakdown - Magnetic Resonance Segment Breakdown - Computed Tomography Segment Breakdown - X-ray Mammography Segment Breakdown - Interventional X-ray Segment Breakdown - Positron Emission Tomography Segment Breakdown - Germany Breakdown - France Breakdown - The United Kingdom Breakdown - Italy Breakdown - Spain Breakdown - Benelux Breakdown - Scandinavia Breakdown - Poland Breakdown - Hungary Breakdown - The Czech Republic Breakdown - Bulgaria Breakdown - Romania Breakdown - The Last Word For more information visit http://www.researchandmarkets.com/research/8x...sis_of_the About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Positron Corporation elects Joseph Oliverio as president
M2 - Fri Nov 15, 6:44AM CST
Nuclear medicine company Positron Corporation (OTC Markets
OSC) stated on Thursday that it has hired Joseph G. Oliverio as its president. Positron Appoints Joseph Oliverio As President
PR Newswire - Thu Nov 14, 4:09PM CST
Positron Corporation (OTCBB
OSC) (the "Company"), a nuclear medicine healthcare company, is pleased to announce the appointment of Joseph G. Oliverio as its President. Mr. Oliverio will direct the Company's cardiac PET mission and oversee Positron's PET technology, radiopharmaceutical partnerships, clinical and technical applications for new customer sales and exiting users. Global Positron Emission Tomography Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
PR Newswire - Thu Nov 07, 3:30AM CST
New Market Research Report Added in MarketResearchReports.Biz Reports Database: Global Positron Emission Tomography Market 2012-2016
Global Radiopharmaceuticals Market Report 2013 - 2018
M2 - Wed Nov 06, 5:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/q28q7t/radiopharmaceutica) has announced the addition of the "Global Radiopharmaceuticals Market Report 2013 - 2018" report to their offering. Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage, bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of iron metabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow of cerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroid diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin B12 from intestines, red blood cell diseases, salivary gland diseases, spleen diseases, stomach and intestinal bleeding, stomach problems, tear duct blockage, thyroid diseases, thyroid cancer and urinary bladder diseases. This may be given to the patient in a number of ways, for e.g. they may be given through the mouth, through injections or placed into the eye or into the bladder. It is a small treatment, which includes use of simple substances containing radioactive isotopes. While treating cancer, these radioactive agents are taken up in the cancerous area to destroy the affected tissues. It works effectively by targeting the areas in the body where the cancer is present. Individuals are suggested to intake radiopharmaceuticals only under the direct supervision of a doctor. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Global Radiopharmaceuticals Market Overview 4 Market Definition & Supply Chain Analysis 5 Global Radiopharmaceutical Generators Market 5.1 Overview 5.2 Mo-99/Tc-99m Generators 5.3 Sr-82/Rb-82 Generators 5.4 Ge-68/Ga-67,68 Generators 5.5 Sr-90/Y-90 Generators 5.6 W-188/Re-188 Generators 6 Global Radiopharmaceuticals Market, By End-User Groups 7 Global Radiopharmaceuticals Market, By Applications 7.1 Overview 7.2 Radiopharmaceuticals For Diagnosis 7.3 Radiopharmaceuticals For Therapy 7.4 Theranostics 8 Global Radiopharmaceuticals Market, By Geography 8.1 Overview 8.2 North America 8.3 Europe 8.4 Asia-Pacific (Apac) 8.5 Rest of the World (RoW) 9 Market Share Analysis By Key Players 9.1 Radiopharmaceuticals Market 9.2 Generators Market 10 Recommendations 11 Company Profiles Companies Mentioned - Cardinal Health Inc. - Covidien Plc - GE Healthcare - IBA Group - Lantheus Medical Imaging - Monrol Nuclear Products, Inc. - Nordion, Inc. - NTP Radioisotopes (Pty) Ltd - Polatom - Positron Corporation - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/q2...rmaceutica
Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI) Worth $5 Billion - 2017 - New Report by MarketsandMarkets
PRWeb - Sat Nov 02, 11:01AM CDT
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017", is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
Global Healthcare/Medical Simulation Market Repor 2013-2017: By Product, Technology, End-Users & Services Analysis
M2 - Fri Nov 01, 9:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4c3qmq/healthcaremedical) has announced the addition of the "Global Healthcare/Medical Simulation Market Repor 2013-2017" report to their offering. 'Healthcare/Medical Simulation Market - By Product (Patient Simulator, Surgical Simulator, Imaging Simulation, Task Trainer), Technology (Haptic, Virtual Reality), End-Users (Academics, Hospitals, Military) & Services- Trends & Global Forecasts To 2017' This research report largely categorizes the global market for healthcare/medical simulation into products and services. This market is broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. The market is also evaluated by end-users and comprehensively analyzed at a granular level by region (North America, Europe, Asia, and Rest of the World). Global Healthcare/medical simulation Products & Services Market: - High Fidelity Mannequin/ Patient Simulators - Simulated Clinical Environments - Live environments - Virtual environments - Second life - Serious games - Interventional simulation - Surgical simulators - Cardiovascular simulators - IV simulators - Endovascular simulators - Ultrasound simulators - Mid / Low Fidelity Task Trainers - Imaging Simulation - Ultrasound Imaging - Magnetic Resonance Imaging (MRI) - Computed Tomography (CT) - Positron Emission Tomography (PET) - Performance Recording - Healthcare/medical simulation training services Technology Landscape: - Haptics - Virtual reality Global Healthcare / Medical Simulation Market, by End-Users: - Academics - Hospitals - Military - Other Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Medical Simulation Products & Services Market 5 Technology Landscape 6 Applications Market 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - B Scientific Gmbh - Anesoft Corporation - Anomalous Medical - Biodigital Systems, Llc - B-Line Medical, Llc (Subsidiary Ofatellis, Inc. ) - CAE, Ltd. - Education Management Solutions, Inc. (EMS) - Gaumard Scientific Company, Inc. - Immersion Corporation - Ingmar Medical, Ltd. - Kyoto Kagaku Co., Ltd. - Laerdal Medical AS - Limbs & Things Ltd - Medical Simulation Corporation - Mentice AB - Promodel Corporation - Simbionix Usa Corporation - Simulab Corporation - Surgical Science Sweden AB For more information visit http://www.researchandmarkets.com/research/4c...aremedical
Global Positron Emission Tomography Market 2012-2016
M2 - Wed Oct 30, 4:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3qdnd8/global_positron) has announced the addition of the "Global Positron Emission Tomography Market 2012-2016" report to their offering. Global Positron Emission Tomography Market Expected To Grow At A CAGR Of 3.74 Percent Over The Period 2012-2016 The report, the Global PET Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. Commenting on the report, an analyst from the researchers' team said: The combination of PET with other imaging equipment such as MRI, CT, and X-ray will provide high-resolution images of the physiological and anatomical behavior of the body. This will in turn help to understand the disease in an effective way. Currently, only the top three companies in the market have introduced hybrid systems such as PET/MRI technology, namely, GE Healthcare, Siemens Healthcare and Philips Healthcare. Siemens Healthcare's Biograph mMR is the most advanced hybrid comprising of a PET/CT that scans the patients once and takes only 30 minutes for imaging and generating the image. This equipment is currently used for clinical research at Massachusetts General Hospital. Currently, PET/MRI scanning is limited to the experimental stage; however, with the development of new tracer molecules and the optimization of PET/MRI procedures, it could boost the use of PET/MRI scanning methods in clinical settings. GE Healthcare is also in the process of developing trimodality scanning equipment consisting of PET/CT/MRI scanning. The trend toward the development of fusion modalities is expected to revolutionize the Global PET market. According to the report, one of the major drivers in this market is the increase in the aging population. The increase in the aging population has led to a high incidence of diseases such as cancer, Alzheimer's, and cardiovascular disorders. This is expected to boost the procurement of PET scanners in all the geographical regions. Further, the report states that one of the major challenges in this market is the economic recession and its impact, especially in the EMEA region. This is expected to reduce the adoption rate of PET scanners and thereby reduce the potential revenues for the market. The major factor for this is the fluctuations in regional currencies. The poor economy is also expected to further reduce the reimbursement options and support from the individual governments. Key Topics Covered 1. Executive Summary 2. Scope of the Report 3. Market Research Methodology 4. List of Abbreviations 5. Introduction 6. Market Landscape 7. Market Segmentation by Application 8. Market Segmentation by Technology 9. Geographical Segmentation 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Key Vendor Analysis Companies Mentioned - Capintec - GE Healthcare - Hitachi Medical systems USA - Mediso Medical Imaging Systems - Naviscan - Philips Healthcare - Positron Corp. - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/3q...l_positron About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
(0)
(0)Positron Corp. (POSC) Stock Research Links
Scroll down for more posts ▼